Reuters: World should not be complacent after COVID-19 vaccine news: WHO
“The World Health Organization (WHO) welcomed Moderna reporting on Monday that its experimental vaccine showed 94.5% efficacy but said that ‘many questions’ remained and it was no time for complacency…” (Nebehay/Farge, 11/16).

Reuters: WHO sees limited COVID-19 vaccine doses in early 2021
“The World Health Organization’s chief scientist said on Monday she expected there to be ‘very limited’ COVID-19 vaccine doses available in the first half of 2021…” (Shields et al., 11/16).

VOA News: WHO Says Vaccine Announcement Encouraging, More Data Needed
“…WHO Chief Scientist Soumya Swaminathan said that level of efficacy in this vaccine, as well as the Pfizer/BioNTech vaccine candidate announced last week, is very encouraging. But, she said, there are many questions remaining about the duration of protection they provide, the impact on severe cases of the virus, the impact on different subpopulations, especially the elderly, as well as the adverse events beyond a certain period. Swaminathan said she hoped the clinical trials would continue to collect data to answer these questions…” (11/16).

Washington Post: WHO tempers prospect of a coronavirus vaccine with warning of a long fight to come
“…The caution at the world’s top public health body was not directed toward the achievements of Moderna and other vaccine developers, but at creating a realistic understanding of the enormous task of immunization. Supply and delivery will pose high hurdles, among others, even if a vaccine is highly effective, according to public health experts…” (Taylor, 11/16).

Additional coverage of SARS-CoV-2 vaccine research and delivery is available from Axios, Bloomberg, CNBC, The Guardian, POLITICO, Homeland Preparedness News, New York Times (2), NPR (2), Reuters (2) (3), Science, STAT, Telegraph, and VOA News.